Skip to main content
. 2021 Oct 12;126(11):8935–8955. doi: 10.1007/s11192-021-04154-z

Table 3.

Second order Country, Research area, Document type, Funding, Opioid harms and Opioid tapering by time period (1975–1985, 1986–2003 and 2004–2019)

Variable Outcome Total (%) Number (%) 1975–1985 Number (%) 1986–2003 Number (%) 2004–2019 p
Country United States 1960 (57.7) 244 (75.3) 360 (49.7) ↓ 1356 (57.7)  < 0.0001
Canada 216 (6.4) 24 (7.4) 50 (6.9) 142 (6.0)
England 211 (6.2) 6 (1.8) 91 (12.6) 114 (4.8)
Germany 181 (5.3) 4 (1.2) 57 (7.8) 120 (5.1)
Australia 170 (5.0) 7 (2.2) 40 (5.5) 123 (5.2)
Sweden 96 (2.8) 26 (8.0) 32 (4.4) 38 (1.6)
Netherlands 87 (2.6) 2 (0.6) 36 (5.0) 49 (2.0)
Other 477 (14.0) 11 (3.4) 58 (8.0) 408 (17.4)
TOTAL 3398 (100.0) 324 (9.5) 724 (21.3) 2350 (69.2)
Research area NEURO 1224 (23.6) 82 (17.2) 308 (26.6) ↑ 834 (23.6)  < 0.0001
ANESTH 1003 (19.4) 76 (15.9) 239 (20.6) ↑ 688 (19.4)
GIM 638 (12.3) 24 (5.0) 87 (7.5) 527 (14.9) ↑
PSYCH 634 (12.2) 170 (35.6) 183 (15.8) ↓ 281 (8.0) ↓
REHAB 303 (5.9) 44 (9.2) 94 (8.1) 165 (4.7) ↓
OTHER 1366 (26.4) 82 (17.2) 246 (21.2) 1038 (29.4)
Document type Article 2518 (74.1) 238 (73.5) 571 (78.9) 1709 (72.7)  < 0.0001
Review 694 (20.4) 69 (21.3) 121 (16.7) 504 (21.4)
Editorial 149 (4.4) 4 (1.2) 22 (3.0) ↑ 123 (5.2) ↑
Other 37 (1.1) 13 (4.0) 10 (1.4) 14 (0.6)
Funding Any industry 165 (4.9) 0 (0.0) 0 (0.0) 165 (7.0)  < 0.0001
No industry 1020 (30.0) 19 (5.9) 66 (9.1) 935 (39.8) ↑
Not reported 2213 (65.1) 305 (94.1) 658 (90.9) 1250 (53.2) ↓
Reference to opioid harms Agenda-setting 997 (29.3) 17 (5.2) 109 (15.0) ↑ 871 (37.1) ↑  < 0.0001
Mention only 335 (9.9) 11 (3.4) 10 (1.4) 314 (13.4) ↑
No mention 2066 (60.8) 296 (91.4) 605 (83.6) 1165 (49.6) ↓
Opioid tapering Required 2151 (63.3) 184 (56.8) 392 (54.1) 1575 (67.0) ↑  < 0.0001
Not required 1247 (36.7) 140 (43.2) 332 (45.9) 775 (33.0) ↓

Bolding and arrows indicate trends of relevance

NEURO neuroscience/neurology, ANESTH anesthesia, GIM general internal medicine, PSYCH psychiatry/psychology, REHAB rehabilitation